NRG Oncology/NSABP B-51/RTOG 1304: Phase III trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to whole breast RT post breast-conserving surgery (BCS) reduces invasive breast cancer recurrence-free interval (IBCR-FI) in patients (pts) with pathologically positive axillary (PPAx) nodes who are ypN0 after neoadjuvant chemotherapy (NC).

Eleftherios P. Mamounas,Hanna Bandos,Julia White,Thomas B. Julian,Atif J. Khan,Simona F. Shaitelman,Mylin A. Torres,Frank A. Vicini,Patricia A. Ganz,Susan Ann McCloskey,Soonmyung Paik,Nilendu Gupta,X. Allen Li,D.J. DiCostanzo,Walter J. Curran,Norman Wolmark

NRG Oncology/NSABP B-51/RTOG 1304: Phase III trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to whole breast RT post breast-conserving surgery (BCS) reduces invasive breast cancer recurrence-free interval (IBCR-FI) in patients (pts) with pathologically positive axillary (PPAx) nodes who are ypN0 after neoadjuvant chemotherapy (NC).

2019

Eleftherios P. Mamounas
Hanna Bandos
Julia White
Thomas B. Julian
Atif J. Khan
Simona F. Shaitelman
Mylin A. Torres
Frank A. Vicini
Patricia A. Ganz
Susan Ann McCloskey
Soonmyung Paik
Nilendu Gupta
X. Allen Li
D.J. DiCostanzo
Walter J. Curran
Norman Wolmark

TPS600Background: This phase III post-NC trial evaluates if CWRNRT post-Mx or whole breast irradiation (WBI) with RNRT after BCS significantly reduces the IBCR-FI rate in pts with PPAx nodes that a...

Keywords:

Medicine
Oncology
Whole Breast Irradiation
breast cancer recurrence
Internal medicine
Breast-conserving surgery
in patient
Radiation therapy
free interval
post mastectomy
Chemotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations